Mukka Proteins delays Vietnam acquisition to Dec 2026

1 min read     Updated on 01 Jul 2026, 06:44 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Mukka Proteins Ltd has delayed its acquisition of a 70% stake in Mukka Proteins Vietnam Co., Ltd. to 31 December 2026 due to pending regulatory approvals. The transaction, valued at up to ₹10,00,000, was initially slated for completion by 30 June 2026.

powered bylight_fuzz_icon
44358414

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Ltd has announced a delay in its acquisition of Mukka Proteins Vietnam Co., Ltd., pushing the revised completion date to 31 December 2026. The company attributed the postponement to delays in securing necessary regulatory approvals in Vietnam. This development impacts the proposed purchase of a 70% stake in the target entity through share transfer.

The acquisition was initially expected to be completed by 30 June 2026. The company had previously submitted intimations regarding this transaction on 26 July 2025, 4 August 2025, and 31 December 2025 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The total consideration for the acquisition does not exceed ₹10,00,000. Mukka Proteins stated that all necessary steps are being taken to address the delays and complete the acquisition in due course.

Acquisition Details

Details of the acquisition
Name of the Acquiring Company Mukka Proteins Limited
Name of the Target Company Mukka Proteins Vietnam Co., Ltd.
Announcement Date 26th July 2025 and 31st December 2025
Expected Date of Completion of Acquisition 30th June 2026
Revised Date of Completion 31st December 2026
Reason for Delay Delay in getting the regulatory approvals in Vietnam

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.07%-3.31%+6.16%+1.54%-22.86%-45.37%

What specific regulatory hurdles in Vietnam are causing the delay, and are they industry-specific?

How will this extended timeline impact Mukka Proteins' strategic expansion plans in Southeast Asia?

Could further delays be anticipated, and what contingency plans are in place if approvals are not secured by December 2026?

Mukka Proteins acquires 51% in Delta Marine for ₹11.10 crore

1 min read     Updated on 26 Jun 2026, 04:55 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Mukka Proteins Limited has acquired a 51% stake in Delta Marine Products for ₹11.10 crore via capital contribution to expand its core business. The target, incorporated on August 12, 2023, manufactures fish meal and oil, reporting a turnover of ₹28.17 crore for FY 2024-25 against a loss of ₹1.97 crore.

powered bylight_fuzz_icon
43928317

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has completed the acquisition of a 51% stake in Delta Marine Products, a partnership firm, for ₹11.10 crore. The transaction was executed through capital contribution on June 25, 2026, as part of the company's strategic investment plans to expand its core business. This acquisition is expected to enhance production efficiency and broaden market reach through capacity expansion and optimization of operational processes.

The disclosure was submitted to the National Stock Exchange of India and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the acquisition does not constitute a related party transaction and that no specific governmental or regulatory approvals were required for the completion of the deal.

Delta Marine Products operates in the manufacturing sector, specifically producing fish meal and fish oil. The entity was incorporated on August 12, 2023, and operates solely within India. The acquisition provides Mukka Proteins with controlling interest in the firm, aligning with its objective to strengthen its position in the fish meal and fish oil market.

The financial performance of Delta Marine Products shows significant growth in turnover over the past year. The firm reported a turnover of ₹28,16,99,338 for FY 2024-25, compared to ₹3,64,15,650 in the previous fiscal year ending March 2024. However, the entity recorded a Profit After Tax (PAT) of ₹(19,72,919) for FY 2024-25.

Financial Overview of Delta Marine Products

Metric Details
Turnover (FY 2024-25) ₹28,16,99,338
Turnover (March 2024) ₹3,64,15,650
PAT (FY 2024-25) ₹(19,72,919)
Date of Incorporation 12-08-2023

The consideration for the acquisition was paid entirely in cash. The investment is intended to drive operational synergies and support the strategic growth initiatives of Mukka Proteins in the manufacturing of steam dried fish meal, fish oil, and fish soluble paste.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.07%-3.31%+6.16%+1.54%-22.86%-45.37%

What specific operational synergies does Mukka Proteins expect to realize to turn Delta Marine Products profitable given its recent net loss?

How will this acquisition impact Mukka Proteins' overall margins and earnings per share in the upcoming fiscal year?

Does Mukka Proteins plan to acquire the remaining 49% stake in Delta Marine Products in the future?

More News on Mukka Proteins

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-22.86%